Alexander Y. Tokman - 23 Nov 2022 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Alexander Tokman by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
23 Nov 2022
Net transactions value
+$1,700
Form type
4
Filing time
28 Nov 2022, 16:00:17 UTC
Previous filing
24 Aug 2022
Next filing
01 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Purchase $1,700 +10,000 +6.5% $0.1700 162,857 23 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.